Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05620641

Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy

Conditions: Post Operative Nausea and Vomiting, Sleeve Gastrectomy, Morbid Obesity

Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: 1
Phase: PHASE3
Enrollment: 100
Sponsor: Tanta University

Location: Egypt

Summary

The aim of this study is to compare the possible efficacy of ondansetron and gabapentin on postoperative nausea and vomiting in patient with morbid obesity who will undergo laparoscopic sleeve gastrectomy.

Eligibility Criteria

Inclusion Criteria:Both male and female patients will be included.Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥35 kg/m2 with the presence of comorbidity such as hypertension, arthritis, and diabetes.Morbidly obese patients scheduled for sleeve gastrectomy with BMI ≥ 40 kg/m2 without comorbidity.Patients fit for anesthesia and surgery.Exclusion Criteria:- Patients with BMI >55 kg/m2.Patients with previous procedures for the treatment of obesity.Pregnant females and lactating women.Patients with psychological or psychiatric diseaseAdministration of antiemetic medication or systemic corticosteroids within 24 hours before surgeryPatients who experienced vomiting within 24 hours before surgery.Patients with history of alcohol or drug abuse.Patients with hypersensitivity or contraindications to any of the drugs used in this study.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05620641). StuddyBuddy aggregates publicly available trial information.